Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy

View through CrossRef
Abstract A novel canine muscular dystrophy in Landseer dogs was observed. We had access to five affected dogs from two litters. The clinical signs started at a few weeks of age, and the severe progressive muscle weakness led to euthanasia between 5 and 15 months of age. The pedigrees of the affected dogs suggested a monogenic autosomal-recessive inheritance of the trait. Linkage and homozygosity mapping indicated two potential genome segments for the causative variant on chromosomes 10 and 31 harboring a total of 4.8 Mb of DNA or 0.2% of the canine genome. Using the Illumina sequencing technology, we obtained a whole-genome sequence from one affected Landseer. Variants were called with respect to the dog reference genome and compared with the genetic variants of 170 control dogs from other breeds. The affected Landseer dog was homozygous for a single, private nonsynonymous variant in the critical intervals, a nonsense variant in the COL6A1 gene (Chr31:39,303,964G>T; COL6A1:c.289G>T; p.E97*). Genotypes at this variant showed perfect concordance with the muscular dystrophy phenotype in all five cases and more than 1000 control dogs. Variants in the human COL6A1 gene cause Bethlem myopathy or Ullrich congenital muscular dystrophy. We therefore conclude that the identified canine COL6A1 variant is most likely causative for the observed muscular dystrophy in Landseer dogs. On the basis of the nature of the genetic variant in Landseer dogs and their severe clinical phenotype these dogs represent a model for human Ullrich congenital muscular dystrophy.
Title: A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy
Description:
Abstract A novel canine muscular dystrophy in Landseer dogs was observed.
We had access to five affected dogs from two litters.
The clinical signs started at a few weeks of age, and the severe progressive muscle weakness led to euthanasia between 5 and 15 months of age.
The pedigrees of the affected dogs suggested a monogenic autosomal-recessive inheritance of the trait.
Linkage and homozygosity mapping indicated two potential genome segments for the causative variant on chromosomes 10 and 31 harboring a total of 4.
8 Mb of DNA or 0.
2% of the canine genome.
Using the Illumina sequencing technology, we obtained a whole-genome sequence from one affected Landseer.
Variants were called with respect to the dog reference genome and compared with the genetic variants of 170 control dogs from other breeds.
The affected Landseer dog was homozygous for a single, private nonsynonymous variant in the critical intervals, a nonsense variant in the COL6A1 gene (Chr31:39,303,964G>T; COL6A1:c.
289G>T; p.
E97*).
Genotypes at this variant showed perfect concordance with the muscular dystrophy phenotype in all five cases and more than 1000 control dogs.
Variants in the human COL6A1 gene cause Bethlem myopathy or Ullrich congenital muscular dystrophy.
We therefore conclude that the identified canine COL6A1 variant is most likely causative for the observed muscular dystrophy in Landseer dogs.
On the basis of the nature of the genetic variant in Landseer dogs and their severe clinical phenotype these dogs represent a model for human Ullrich congenital muscular dystrophy.

Related Results

COL6A1 related muscular dystrophy in Landseer dogs: A canine model for Ullrich congenital muscular dystrophy
COL6A1 related muscular dystrophy in Landseer dogs: A canine model for Ullrich congenital muscular dystrophy
AbstractBackgroundCollagen VI related myopathies are congenital diseases of variable phenotype. The severe phenotype is referred to as Ullrich congenital muscular dystrophy. In thi...
Oxidative stress biomarkers in hypothyroid, non thyroid illness and euthyroid dogs
Oxidative stress biomarkers in hypothyroid, non thyroid illness and euthyroid dogs
AbstractThere are only a few numbers of published reports available on oxidative stress parameters in hypothyroidism and many of which are in the field of human medicine. Studies o...
Role of Growth Factors and Apoptosis Proteins in Cognitive Disorder Development in Patients with Duchenne Muscular Dystrophy
Role of Growth Factors and Apoptosis Proteins in Cognitive Disorder Development in Patients with Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease; it occurs due to a mutation in the dystrophin protein gene; as a result, the protein is not synthesized an...
The MRL Mitochondrial Genome Decreases Murine Muscular Dystrophy Severity
The MRL Mitochondrial Genome Decreases Murine Muscular Dystrophy Severity
It is well known that muscular dystrophy disease severity is controlled by genetic modifiers. The expectation is that by identifying these modifiers, we can illuminate additional t...
Dystrophin (DMD) Missense Variant in Cats with Becker-Type Muscular Dystrophy
Dystrophin (DMD) Missense Variant in Cats with Becker-Type Muscular Dystrophy
Muscular dystrophy due to dystrophin deficiency in humans is phenotypically divided into a severe Duchenne and milder Becker type. Dystrophin deficiency has also been described in ...
Duchenne Muscular Dystrophy: Clinical Characteristics, Molecular Mechanisms and Management
Duchenne Muscular Dystrophy: Clinical Characteristics, Molecular Mechanisms and Management
The dystrophinopathies encompass a range of X-linked muscle disorders varying from mild to severe, including Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and...

Back to Top